156 related articles for article (PubMed ID: 33676446)
1. Screening is associated with lower mastectomy rates in eastern Switzerland beyond stage effects.
Herrmann C; Morant R; Walser E; Mousavi M; Thürlimann B
BMC Cancer; 2021 Mar; 21(1):229. PubMed ID: 33676446
[TBL] [Abstract][Full Text] [Related]
2. Breast cancer patients enrolled in the Swiss mammography screening program "donna" demonstrate prolonged survival.
Kuklinski D; Blum M; Subelack J; Geissler A; Eichenberger A; Morant R
Breast Cancer Res; 2024 May; 26(1):84. PubMed ID: 38802897
[TBL] [Abstract][Full Text] [Related]
3. Impact of mammography screening programmes on breast cancer mortality in Switzerland, a country with different regional screening policies.
Herrmann C; Vounatsou P; Thürlimann B; Probst-Hensch N; Rothermundt C; Ess S
BMJ Open; 2018 Mar; 8(3):e017806. PubMed ID: 29540406
[TBL] [Abstract][Full Text] [Related]
4. Trends in Breast Cancer Incidence and Stage Distribution Before and During the Introduction of the Mammography Screening Program in Lithuania.
Steponaviciene L; Briediene R; Vanseviciute R; Smailyte G
Cancer Control; 2019; 26(1):1073274818821096. PubMed ID: 30808202
[TBL] [Abstract][Full Text] [Related]
5. Trends in surgical treatment for breast cancer in Germany after the implementation of the mammography screening program.
Trocchi P; Kuss O; Kääb-Sanyal V; Heidinger O; Stang A
Eur J Epidemiol; 2019 Dec; 34(12):1143-1150. PubMed ID: 31650416
[TBL] [Abstract][Full Text] [Related]
6. Comparison between opportunistic and organised breast cancer mammography screening in the Swiss canton of Fribourg.
Peisl S; Zimmermann S; Camey B; Betticher D; Bouchardy C
BMC Cancer; 2019 May; 19(1):469. PubMed ID: 31101028
[TBL] [Abstract][Full Text] [Related]
7. The incidence of interval cancers in the German mammography screening program: results from the population-based cancer registry in North Rhine-Westphalia.
Heidinger O; Batzler WU; Krieg V; Weigel S; Biesheuvel C; Heindel W; Hense HW
Dtsch Arztebl Int; 2012 Nov; 109(46):781-7. PubMed ID: 23264826
[TBL] [Abstract][Full Text] [Related]
8. Monitoring and evaluation of breast cancer screening programmes: selecting candidate performance indicators.
Muratov S; Canelo-Aybar C; Tarride JE; Alonso-Coello P; Dimitrova N; Borisch B; Castells X; Duffy SW; Fitzpatrick P; Follmann M; Giordano L; Hofvind S; Lebeau A; Quinn C; Torresin A; Vialli C; Siesling S; Ponti A; Giorgi Rossi P; Schünemann H; Nyström L; Broeders M;
BMC Cancer; 2020 Aug; 20(1):795. PubMed ID: 32831048
[TBL] [Abstract][Full Text] [Related]
9. Effect of mammography screening on surgical treatment for breast cancer: a nationwide analysis of hospitalization rates in Germany 2005-2009.
Stang A; Kääb-Sanyal V; Hense HW; Becker N; Kuss O
Eur J Epidemiol; 2013 Aug; 28(8):689-96. PubMed ID: 23775424
[TBL] [Abstract][Full Text] [Related]
10. Effect of mammography screening on surgical treatment for breast cancer in Norway: comparative analysis of cancer registry data.
Suhrke P; Mæhlen J; Schlichting E; Jørgensen KJ; Gøtzsche PC; Zahl PH
BMJ; 2011 Sep; 343():d4692. PubMed ID: 21914765
[TBL] [Abstract][Full Text] [Related]
11. Reduction in advanced breast cancer after introduction of a mammography screening program in Tyrol/Austria.
Oberaigner W; Geiger-Gritsch S; Edlinger M; Daniaux M; Knapp R; Hubalek M; Siebert U; Marth C; Buchberger W
Breast; 2017 Jun; 33():178-182. PubMed ID: 28419909
[TBL] [Abstract][Full Text] [Related]
12. [Early effects of attendance to the Friuli Venezia Giulia (Northern Italy) mammography screening programme on the incidence of advanced-stage breast cancer: a cohort study].
Giudici F; Bortul M; Clagnan E; Del Zotto S; Franzo A; Giordano L; Gobbato M; Puliti D; Serraino D; Zucchetto A; Zanier L; Zanconati F; Bucchi L
Epidemiol Prev; 2020; 44(2-3):145-153. PubMed ID: 32631014
[TBL] [Abstract][Full Text] [Related]
13. Breast cancer incidence and mammography screening among resettlers in Germany.
Kaucher S; Khil L; Kajüter H; Becher H; Reder M; Kolip P; Spallek J; Winkler V; Berens EM
BMC Public Health; 2020 Mar; 20(1):417. PubMed ID: 32228537
[TBL] [Abstract][Full Text] [Related]
14. Trends in the use of mammography for early breast cancer detection in Switzerland: Swiss Health Surveys 2007 and 2012.
Fenner L; Kässner A; Berlin C; Egger M; Zwahlen M
Swiss Med Wkly; 2018; 148():w14603. PubMed ID: 29756635
[TBL] [Abstract][Full Text] [Related]
15. Influence of breast cancer opportunistic screening on aesthetic surgical outcome: A single-center retrospective study in Switzerland.
Marcon M; Dedes K; Varga Z; Frauenfelder T; Boss A
Breast J; 2018 May; 24(3):285-290. PubMed ID: 28833850
[TBL] [Abstract][Full Text] [Related]
16. Impact of a mammography screening programme on the breast cancer population of the Region of Valencia (Spain).
Pérez-Fidalgo JA; Miranda J; Chirivella I; Ibáñez J; Bermejo B; Pons C; Melchor I; Santaballa A; Martínez-Ruiz F; Lluch A; Salas D
Clin Transl Oncol; 2008 Nov; 10(11):745-52. PubMed ID: 19015071
[TBL] [Abstract][Full Text] [Related]
17. Incidence of advanced-stage breast cancer in regular participants of a mammography screening program: a prospective register-based study.
Khil L; Heidrich J; Wellmann I; Kääb-Sanyal V; Weigel S; Heindel W; Hense HW; Heidinger O
BMC Cancer; 2020 Mar; 20(1):174. PubMed ID: 32131766
[TBL] [Abstract][Full Text] [Related]
18. Differences in Breast Cancer Characteristics by Mammography Screening Participation or Non-Participation.
Braun B; Khil L; Tio J; Krause-Bergmann B; Fuhs A; Heidinger O; Hense HW
Dtsch Arztebl Int; 2018 Aug; 115(31-32):520-527. PubMed ID: 30149831
[TBL] [Abstract][Full Text] [Related]
19. Introduction of an organised programme and social inequalities in mammography screening: A 22-year population-based study in Geneva, Switzerland.
Sandoval JL; Theler JM; Cullati S; Bouchardy C; Manor O; Gaspoz JM; Guessous I
Prev Med; 2017 Oct; 103():49-55. PubMed ID: 28778819
[TBL] [Abstract][Full Text] [Related]
20. Could Patients Older than 75 Years Benefit from a Systematic Breast Cancer Screening Program?
Ilenko A; Sergent F; Mercuzot A; Zitoun M; Chauffert B; Foulon A; Gondry J; Chevreau J
Anticancer Res; 2017 Feb; 37(2):903-907. PubMed ID: 28179350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
